➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Boehringer Ingelheim
AstraZeneca
McKesson
Johnson and Johnson

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Litigation Details for Recro Gainesville LLC v. Actavis Laboratories FL Inc. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Recro Gainesville LLC v. Actavis Laboratories FL Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Recro Gainesville LLC v. Actavis Laboratories FL Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2017-02-24 139 prosecution of the parent of the '742 patent, U.S. Patent No. 6,228,398, does nothing to undermine the court…Claims and Counterclaims with Respect to U.S. Patent No. 6,228,398. (D.I. 117at1). Case 1:14-cv-01118-GMS Document…, Inc. of U.S. Patent No. 9,132,096 ("the '096 patent") and U:S. Patent No. 6,902,742 (…and '742 patent. C. The Patents-in-Suit 6. The '742 patent, entitled "…claimed in a patent or the use of which is claimed ina patent before the expiration of such patent." External link to document
2014-09-03 5 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398 B1; 6,902,742 B2;. …3 September 2014 1:14-cv-01118 830 Patent None District Court, D. Delaware External link to document
2015-12-29 69 the asserted claims of U.S. Patent Nos. 6,228,398 ("the '398 patent") and 6,902,742 ("… ORDER - Construing the terms of U.S. Patent Nos. 6,228,398 and 6,902,742. Signed by Judge Gregory M… ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 6,228.398 and 6,902,742 After considering …quot;the '742 patent"): 1. The term "following oral delivery to a subject delivers…"the general class of persons to whom the patented compositions are directed, i.e. a patient population External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Johnson and Johnson
Harvard Business School
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.